Keap1-Nrf2 signaling pathway confers resilience versus susceptibility to inescapable electric stress
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
The transcription factor Keap1-Nrf2 signaling plays a key role in the oxidative stress which is involved in psychiatric disorders. In the learned helplessness (LH) paradigm, protein levels of Keap1 and Nrf2 in the prefrontal cortex and dentate gyrus of hippocampus from LH (susceptible) rats were lower than control and non-LH (resilience) rats. Furthermore, protein expressions of Keap1 and Nrf2 in the parietal cortex from major depressive disorder, schizophrenia, and bipolar disorder were lower than controls. These results suggest that Keap1-Nrf2 signaling might contribute to stress resilience which plays a key role in the pathophysiology of psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two post-mortem studies have demonstrated that Nrf2 levels are decreased in hippocampus, prefrontal cortex, and parietal cortex (33, 34).”
From Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway (2019) · cites this paper as [34]
Citations
Cites
1 retracted
Yang, C., Shirayama, Y., Zhang, J.-C., Ren, Q., & Hashimoto, K. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu121 · Cited by 103 · cited 1×
“In addition, we reported that alterations in the levels of BDNF, BDNF pro-peptide and their precursor proBDNF in the PFC and DG of rat brains confer stress resilience [10, 11].”
BackgroundSelf-citationRetractedRole of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903 · cited 3×
“Keap1–Nrf2 signaling pathway plays a key role in the cellular defense against oxidative stress and inflammation [3, 4].”
BackgroundThe role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Psychobiology and molecular genetics of resilience
Feder, A., Nestler, E. J., & Charney, D. S. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2649 · Cited by 1,272 · cited 1×
“Accumulating evidence supports that resilience is involved in the development of psychiatric disorders [1, 2].”
BackgroundRusso, S. J., Murrough, J. W., Han, M.-H., Charney, D. S., & Nestler, E. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3234 · Cited by 1,206
Self-citationToward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680 · cited 5×
“During oxidative stress, Nrf2 is de-repressed and activates the transcription of cytoprotective genes [4].”
BackgroundInfluentialZhang, J.-C., Yao, W., & Hashimoto, K. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160119094646 · Cited by 538
Self-citationThe Stanley Foundation brain collection and Neuropathology Consortium
Torrey, E. F., Webster, M., Knable, M., Johnston, N., & Yolken, R. H. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00192-9 · Cited by 533
Sulforaphane treatment of autism spectrum disorder (ASD)
Singh, K., Connors, S. L., Macklin, E. A., Smith, K. D., Fahey, J. W., Talalay, P., & Zimmerman, A. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416940111 · Cited by 449
Imaizumi, Y., Okada, Y., Akamatsu, W., Koike, M., Kuzumaki, N., Hayakawa, H., Nihira, T., Kobayashi, T., Ohyama, M., Sato, S., et al. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-35 · Cited by 380
Cited by
Arioz, B. I., Tastan, B., Tarakcioglu, E., Tufekci, K. U., Olcum, M., Ersoy, N., Bagriyanik, A., Genc, K., & Genc, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01511 · Cited by 516
“Two post-mortem studies have demonstrated that Nrf2 levels are decreased in hippocampus, prefrontal cortex, and parietal cortex (33, 34).”
BackgroundOxidative Stress‐Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
Ermakov, E. A., Dmitrieva, E. M., Parshukova, D. A., Kazantseva, D. V., Vasilieva, A. R., & Smirnova, L. P. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8881770 · Cited by 233
“Besides, expressions of Nrf2 and Keap1 proteins in the parietal cortex from brain samples of schizophrenia patients were lower than those of healthy individuals [140].”
BackgroundNrf2: An all-rounder in depression
Zuo, C., Cao, H., Song, Y., Gu, Z., Huang, Y., Yang, Y., Miao, J., Zhu, L., Chen, J., Jiang, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102522 · Cited by 145
Yao, W., Lin, S., Su, J. Y., Cao, Q., Chen, Y., Chen, J., Zhang, Z., Hashimoto, K., Qi, Q., & Zhang, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01261-6 · Cited by 114
Self-citationInflammation in Bipolar Disorder (BD): Identification of new therapeutic targets
Pereira, A. C., Oliveira, J. M., Silva, S., Madeira, N. G. G. F., Pereira, C., & Cruz, M. T. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105325 · Cited by 109
Zhang, K., Fujita, Y., Chang, L., Qu, Y., Pu, Y., Wang, S., Shirayama, Y., & Hashimoto, K. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0571-x · Cited by 98
Self-citationEssential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective
Hashimoto, K. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01182 · Cited by 98
Self-citationStenvinkel, P., Meyer, C. J., Block, G. A., Chertow, G. M., & Shiels, P. G. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz120 · Cited by 72
Rossetti, A. C., Paladini, M. S., Riva, M. A., & Molteni, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107520 · Cited by 77
Nrf2 regulates iron-dependent hippocampal synapses and functional connectivity damage in depression
Zeng, T., Li, J., Xie, L., Dong, Z., Chen, Q., Huang, S., Xie, S., Lai, Y., Li, J., Yan, W., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02875-x · Cited by 77
Self-citationIncreasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry
Morris, G., Walker, A. J., Walder, K., Berk, M., Marx, W., Carvalho, A. F., Maes, M., & Puri, B. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02212-w · Cited by 72
Cecerska-Heryć, E., Polikowska, A., Serwin, N., Roszak, M., Grygorcewicz, B., Heryć, R., Michalczyk, A., & Dołęgowska, B. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2021.105269 · Cited by 68
Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders
Singh, A. A., Katiyar, S., & Song, M. (2025) · Brain Sciences · doi:10.3390/brainsci15030252 · Cited by 68
He, L., Zheng, Y., Huang, L., Ye, J., Ye, Y., Luo, H., Chen, X., Yao, W., Chen, J., & Zhang, J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02227-y · Cited by 61
Self-citationYoshino, Y., Roy, B., Kumar, N., Mukhtar, M. S., & Dwivedi, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01159-9 · Cited by 55
Upregulating Nrf2 in the RVLM ameliorates sympatho-excitation in mice with chronic heart failure
Ma, A., Hong, J., Shanks, J. A., Rudebush, T., Yu, L., Hackfort, B. T., Wang, H., Zucker, I. H., & Gao, L. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.002 · Cited by 52
Matsuura, A., Ishima, T., Fujita, Y., Iwayama, Y., Hasegawa, S., Kawahara‐Miki, R., Maekawa, M., Toyoshima, M., Ushida, Y., Suganuma, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20538-3 · Cited by 51
Self-citationMorris, G., Walder, K. R., Berk, M., Marx, W., Walker, A. J., Maes, M. H. J., & Puri, B. K. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05590-5 · Cited by 50
Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity
Cao, Q., Zou, Q., Zhao, X. Y., Zhang, Y., Qu, Y., Wang, N., Murayama, S., Qi, Q., Hashimoto, K., Lin, S., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01063-9 · Cited by 49
Self-citationInflammatory and antioxidant pathway dysfunction in borderline personality disorder
MacDowell, K. S., Díaz‐Marsá, M., Buenache, E., López‐Villatoro, J. M., Moreno, B., Leza, J. C., & Carrasco, J. L. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112782 · Cited by 46
Tang, R., Cao, Q., Hu, S.-W., He, L., Du, P., Chen, G., Fu, R., Xiao, F., Sun, Y., Zhang, J., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00727-z · Cited by 46
Self-citationHashimoto, K. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1063-7 · Cited by 44
Self-citationInduced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?
Morris, G., Puri, B. K., Carvalho, A. F., Maes, M. H. J., Berk, M., Ruusunen, A. A., & OLIVE, L. S. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa008 · Cited by 44
Qu, Y., Shan, J., Wang, S., Chang, L., Pu, Y., Wang, X., Tan, Y., Yamamoto, M. P., & Hashimoto, K. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01208-w · Cited by 44
Self-citationMorris, G., Sominsky, L., Walder, K. R., Berk, M., Marx, W., Carvalho, A. F., Bortolasci, C. C., Maes, M. H. J., & Puri, B. K. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02800-y · Cited by 41
Li, S., Yang, C., Fang, X., Zhan, G., Huang, N., Gao, J., Xu, H., Hashimoto, K., & Luo, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00887 · Cited by 40
Self-citationZhang, J., Chang, L., Pu, Y., & Hashimoto, K. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.128 · Cited by 36
Self-citationThe Nrf2 pathway in psychiatric disorders: pathophysiological role and potential targeting
Bhandari, R., Kaur, J., Kaur, S., & Kuhad, A. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1887141 · Cited by 37
Ahmed, A., Misrani, A., Tabassum, S., Yang, L., & Long, C. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.05.028 · Cited by 35
Zhang, J., Tan, Y., Chang, L., Hammock, B. D., & Hashimoto, K. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.070 · Cited by 34
Self-citationMorris, G., Gamage, E., Travica, N., Berk, M., Jacka, F. N., O'Neil, A. E., Puri, B. K., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.036 · Cited by 34
Xiong, Z., Zhang, K., Ren, Q., Chang, L., Chen, J., & Hashimoto, K. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.016 · Cited by 34
Self-citationThe compensatory antioxidant response system with a focus on neuroprogressive disorders
Morris, G., Puri, B. K., Walker, A. J., Berk, M., Walder, K. R., Bortolasci, C. C., Marx, W., Carvalho, A. F., & Maes, M. H. J. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109708 · Cited by 34
Luan, D., Zhao, M., Shi, Y., Li, L., Cao, Y.-J., Feng, H., & Zhang, Z. (2020) · World Journal of Psychiatry · doi:10.5498/wjp.v10.i10.223 · Cited by 31
Subba, R., Ahmad, M. H., Ghosh, B., & Mondal, A. C. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174993 · Cited by 31
Wei, Y., Chang, L., Liu, G., Wang, X., Yang, Y. H., & Hashimoto, K. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109098 · Cited by 30
Self-citationBiological mechanisms and clinical efficacy of sulforaphane for mental disorders
Zheng, W., Li, X., Zhang, T., & Wang, J. (2022) · General Psychiatry · doi:10.1136/gpsych-2021-100700 · Cited by 29
NLRP3 inflammatory pathway. Can we unlock depression?
Jahromi, G. G., Razi, S., & Rezaei, N. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148644 · Cited by 26
Li, X., Deng, A., Liu, J., & Hou, W. (2018) · PubMed · Cited by 22
He, L., Mo, X., He, L., Ma, Q., Cai, L., Zheng, Y., Huang, L., Lin, X., Wu, M.-S., Ding, W., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.155332 · Cited by 20
Self-citationPu, Y., Qu, Y., Chang, L., Wang, S., Zhang, K., Ushida, Y., Suganuma, H., & Hashimoto, K. (2019) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12060 · Cited by 20
Self-citationBeeraka, N. M., Ávila-Rodriguez, M., & Aliev, G. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02703-4 · Cited by 21
Wang, X., Liu, J., Zhiping, D., & Sui, Y. (2021) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2021.05.007 · Cited by 19
The regulation of animal behavior by cellular stress responses
Özbey, N. P., Thompson, M. A., & Taylor, R. C. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112720 · Cited by 18
López‐Villatoro, J. M., Díaz‐Marsá, M., de la Torre‐Luque, A., MacDowell, K. S., Prittwitz, C., Leza, J. C., & Carrasco, J. L. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2023.2183254 · Cited by 14
KEAP1‐NRF2/HO‐1 Pathway Promotes Ferroptosis and Neuronal Injury in Schizophrenia
Zhu, F., Dan, T., & Hua, S. (2025) · Brain and Behavior · doi:10.1002/brb3.70311 · Cited by 13
Huang, L., He, L., Ma, R., Ding, W., Zhou, C., Lin, S., Zhang, J., Chen, J., & Yao, W. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06176-8 · Cited by 13
Self-citationNRF2, KEAP1 and GSK-3 levels in autism spectrum disorder: a case control study
Turğut, F. S., Karadağ, M., Tayşi, S., Hangül, Z., & Gökçen, C. (2023) · International Journal of Developmental Disabilities · doi:10.1080/20473869.2023.2185959 · Cited by 12
López‐Villatoro, J. M., de la Torre‐Luque, A., MacDowell, K. S., Gálvez-Merlín, A., del Barrio, A. G., Beato‐Fernández, L., Ruiz-Guerrero, F., Mola-Cardenes, P., Polo, F., León-Velasco, M., et al. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110927 · Cited by 11
Intracellular Signaling Pathways Implicated in the Pathophysiology of Depression
Réus, G. Z., Generoso, J. S., Rodrigues, A. L. S., & Quevedo, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00010-x · Cited by 10
Lai, M., Su, D., Ai, Z., Yang, M., Zhang, Z., Zhang, Q., Shao, W., Luo, T., Zhu, G., & Song, Y. (2024) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgae082 · Cited by 9
Yang, N., Wang, Y., Luo, X., & Zhan, G. (2024) · Stress · doi:10.1080/10253890.2024.2316050 · Cited by 9
The role of reactive oxygen species in the pathogenic pathways of depression
Ibi, M., & Yabe‐Nishimura, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817780-8.00001-3 · Cited by 9
Wu, C., Chen, X., Lai, J., Xu, Y., & Hu, S. (2020) · Medicine · doi:10.1097/md.0000000000020981 · Cited by 7
Dinice, L., Cosimi, P., Esposito, G., Scarinci, F., Cacciamani, A., Cafiero, C., Placentino, L., Ripandelli, G., & Micera, A. (2025) · Antioxidants · doi:10.3390/antiox14070841 · Cited by 6
Effects of curcumin and melatonin treatment in the cerebral cortex of adult rats
MUTLU, Ç. Y., Aktan, A. K., & AKBULUT, K. G. (2023) · General Physiology and Biophysics · doi:10.4149/gpb_2022047 · Cited by 6
Mitochondrial Insights into Lithium Response in Bipolar Disorder: A State-of-the-Art Review
Balaç, S., Dal, F., Karaçiçek, B., Akşahin, İ. C., Pisanu, C., Şenol, Ş. H., Manchia, M., Meloni, A., Damri, O., Agam, G., et al. (2025) · Neuropsychobiology · doi:10.1159/000549993 · Cited by 4
Faborode, O. S., Dallé, E., & Mabandla, M. V. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105170 · Cited by 4
Nrf2 Dysregulation in Major Depressive and Bipolar Disorders
Hashemi, M., Ghanbarirad, M., Saberi, S. M., & Majd, A. (2021) · Galen Medical Journal · doi:10.31661/gmj.v10i.2074 · Cited by 2
Convolvulus pluricaulis usage and depression
Shah, P. D., & Gupta, G. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817935-2.00001-5 · Cited by 2
Shan, J., Qu, Y., & Hashimoto, K. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.027 · Cited by 1
Self-citationDonoso, F. (2019) · Arrow@dit (Dublin Institute of Technology)
Salama, A., Elhadidy, M. E., EL-Kassaby, M. I., & Farrag, A. R. H. (2022) · Egyptian Pharmaceutical Journal · doi:10.4103/epj.epj_53_21
Zeng, T., Li, J., Xie, L., Dong, Z., Chen, Q., Huang, S., Xie, S., Lai, Y., Li, J., Yan, W., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24180905
Self-citationFaborode, O. S. (2021) · ResearchSpace (University of KwaZulu-Natal)
Bipolar disorder and somatic diseases: Focus on oxidative stress markers
Balaç, S., Akşahin, İ. C., Arat-Çelik, H. E., Genç, Ş., & Ceylan, D. (2026) · Neuroscience Applied · doi:10.1016/j.nsa.2026.107002
Epigenetics of bipolar disorder: a bibliometric landscape and visualization analysis
Xiong, L., Fan, H., Gao, J., & Lei, M. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1804155
Demir, B., Sancaktar, M., Sargın, E. N., Elboğa, G., Bülbül, F., Ercan, K., Tayşi, S., & Altındağ, A. (2026) · Neurochemical Journal · doi:10.1134/s181971242670039x
Başer, Ö. F., & Karapehlivan, M. (2026) · Pharmaceuticals · doi:10.3390/ph19071130
Investigating the Role of Oxidative Stress Parameters in the Spectrum of Preschool Anxiety Disorders
Cuhacioglu, E., Doğan, Ö., Ozturk, H. H., & Uytun, M. Ç. (2026) · Early Intervention in Psychiatry · doi:10.1111/eip.70242
Metadata
- Authors
- Zhang, J.-C., Yao, W., Dong, C., Han, M., Shirayama, Y., & Hashimoto, K.
- Affiliations
- Chiba University (JP)
- Corresponding author
- Hashimoto, Kenji
- Venue
- European Archives of Psychiatry and Clinical Neuroscience
- Published
- 2017-11-08
- Volume
- 268
- Issue
- 8
- Pages
- 865-870
- ISSN
- 0003-9373 (ISSN-L)
- 0940-1334
- 1433-8491
- OpenAlex
- W2767612896
- Cited by
- 66
- References
- 26
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 2 · 2023: 8 · 2022: 10 · 2021: 13 · 2020: 12 · 2019: 8 · 2018: 5
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Archives of Psychiatry and Clinical Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Resilience and Mental Health
- Keywords
- Nrf2/Keap1 pathway, oxidative stress, learned helplessness, stress resilience, major depressive disorder, schizophrenia, bipolar disorder, prefrontal cortex, hippocampus, mental illness
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Analysis of Variance, Animals, Mental Disorders, Brain, Disease Models, Animal, Electroshock, Gene Expression Regulation, Helplessness, Learned, Humans, Male, Stress, Psychological, Time Factors, Signal Transduction, Rats, Sprague-Dawley, NF-E2-Related Factor 2, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.